BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laboux T, Gibier JB, Pottier N, Glowacki F, Hamroun A. COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist. J Nephrol 2021;34:373-8. [PMID: 33548053 DOI: 10.1007/s40620-020-00935-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Qamar MA, Kogut LM, Tebha SS, Arif A, Ninmol J, Abdul Razzaque MR, Qamar K, Yosufi A. Collapsing focal segmental glomerulosclerosis secondary to COVID-19: A systematic review and meta-analysis. Ann Med Surg (Lond) 2023;85:92-101. [PMID: 36845824 DOI: 10.1097/MS9.0000000000000107] [Reference Citation Analysis]
2 Papalia G, Barbuto S, Campus A, Vischini G. Double glomerulopathies or two-faced janus? A challenging case in the COVID-19 era. J Nephrol 2023;36:225-8. [PMID: 35666373 DOI: 10.1007/s40620-022-01351-8] [Reference Citation Analysis]
3 Nourmohammadi J, Pediatrics Department, Shahid Hasheminejad Medical Research Center, Mashhad University of Medical Sciences, Iran, Akhondi M, Rajabiniat F, Vaeaz ZS, Nourmohammadi Z, Moghadam MH, Herzzentrum Leipzig, Germany, Shahid Hasheminejad Medical Research Center, Mashhad University of Medical Sciences, Iran, Department of Nursing, Mashhad Branch, Islamic Azad University, Mashhad, I.R.Iran, Torbat-e-Jam Faculty of Medical Sciences, Torbat-e-Jam, Iran, Management Department, Mashhad University of Medical Sciences, Iran. Pharmacological evaluation of glomerulonephritis in Covid-19 patients. RJMM 2022;125:630-635. [DOI: 10.55453/rjmm.2022.125.4.14] [Reference Citation Analysis]
4 Sutar D, Mukerjee N, Mukherjee D, Maitra S, Dey A, Alexiou A, Ghosh A. COVID-19 and HIV-associated Nephropathies: Double Whammy. TOPHJ 2022;15. [DOI: 10.2174/18749445-v15-e2208170] [Reference Citation Analysis]
5 Piko N, Ekart R, Hojs R, Bevc S. COVID-19-Associated Nephropathy: An Emerging Clinical Entity. EMJ Nephrol 2022. [DOI: 10.33590/emjnephrol/22-0005] [Reference Citation Analysis]
6 Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, Hu J, Liu T, Ma K, Han M, Luo X. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022;7:57. [PMID: 35197452 DOI: 10.1038/s41392-022-00907-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
7 Muehlig AK, Gies S, Huber TB, Braun F. Collapsing Focal Segmental Glomerulosclerosis in Viral Infections. Front Immunol 2021;12:800074. [PMID: 35095882 DOI: 10.3389/fimmu.2021.800074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
8 Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [PMID: 34868898 DOI: 10.5500/wjt.v11.i11.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
9 Kudose S, Santoriello D, Bomback AS, Sekulic M, Batal I, Stokes MB, Ghavami IA, Kim JS, Marasa M, Xu K, Peleg Y, Barasch J, Canetta P, Rasouly HM, Gharavi AG, Markowitz GS, D'Agati VD. Longitudinal Outcomes of COVID-19-Associated Collapsing Glomerulopathy and Other Podocytopathies. J Am Soc Nephrol 2021;32:2958-69. [PMID: 34670811 DOI: 10.1681/ASN.2021070931] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
10 Menez S, Parikh CR. Overview of acute kidney manifestations and management of patients with COVID-19. Am J Physiol Renal Physiol 2021;321:F403-10. [PMID: 34448642 DOI: 10.1152/ajprenal.00173.2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]